Search

Author/Creator Faries, Douglas

2. A first step towards best practice recommendations for the design and statistical analyses of pragmatic clinical trials: A modified Delphi approach. Issue 12 (1st July 2022)

Authors:
Palin, Victoria; Van Staa, Tjeerd P.; Steels, Stephanie; Troxel, Andrea B.; Groenwold, Rolf H. H.; MacDonald, Tom M.; Torgerson, David; Faries, Douglas; Mancini, Pierre; Ouwens, Mario; Frith, Lucy J.; Tsirtsonis, Kate; MacLennan, Graham; Nordon, Clementine
Other Names:
Wong Ian guestEditor.; Dewildt Saskia guestEditor.
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 12(2022)
Page Start:
5183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study. Issue 1 (December 2015)

Authors:
Jones, Meghan; Andrews, Jeffrey; Faries, Douglas; Landry, John; Xu, Jenny; Detke, Holland; Chhabra-Khanna, Rashna; McDonnell, David
Journal:
BMC psychiatry
Issue:
Volume 15:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study. Issue 1 (December 2015)

Authors:
Jones, Meghan; Andrews, Jeffrey; Faries, Douglas; Landry, John; Xu, Jenny; Detke, Holland; Chhabra-Khanna, Rashna; McDonnell, David
Journal:
BMC psychiatry
Issue:
Volume 15:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment. (2nd January 2023)

Authors:
Levenson, Mark; He, Weili; Chen, Jie; Fang, Yixin; Faries, Douglas; Goldstein, Benjamin A.; Ho, Martin; Lee, Kwan; Mishra-Kalyani, Pallavi; Rockhold, Frank; Wang, Hongwei; Zink, Richard C.
Journal:
Statistics in biopharmaceutical research
Issue:
Volume 15:Number 1(2023)
Page Start:
3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. DT‐02–04: Excess costs associated with misdiagnosis of Alzheimer's disease among U.S. Medicare beneficiaries with vascular dementia or Parkinson's disease. (1st July 2013)

Authors:
Kirson, Noam; Hunter, Craig; Desai, Urvi; Cummings, Alice; San Roman, Alexandra; Faries, Douglas; Hardwick, Christine; Birnbaum, Howard
Journal:
Alzheimer's & dementia
Issue:
Volume 9:Supplement 4S(2013)Part 21
Page Start:
P845
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study. (12th May 2015)

Authors:
Dennehy, Ellen B.; Robinson, Rebecca L.; Stephenson, Judith J.; Faries, Douglas; Grabner, Michael; Palli, Swetha Rao; Stauffer, Virginia L.; Marangell, Lauren B.
Journal:
Current medical research and opinion
Issue:
Volume 31:Number 6(2015:Jun.)
Page Start:
1165
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗